Option delistings effective March 24th include Aligos Therapeutics (ALGS), Allbirds (BIRD), Biotricity Inc (BTCY), DWTX Stock (DWTX), Dixie Group Inc (DXYN), Genetic Technologies Limited (ADR) (GENE), Galecto (GLTO), ESS Tech (GWH), Trevena Inc (TRVN), and iShares S&P Develpd ex US Prprty Indx Fd (WPS).
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGS:
- Aligos Therapeutics announces inducement grants under Nasdaq listing rule
- Biotech Alert: Searches spiking for these stocks today
- Aligos Therapeutics Faces Challenges in Developing Hepatitis B Treatments Amidst Industry Competition
- Aligos Therapeutics price target lowered to $70 from $75 at H.C. Wainwright
- Aligos Therapeutics Advances Pipeline Amid Financial Challenges